| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data | [1]Fangyuan Li, [2]Jianfang Li, [3]Junxian Yu, [4]Tao Pan, [5]Beiqin Yu, [6]Qingqing Sang, [7]Wentao Dai, [8]Junyi Hou, [9]Chao Yan, [10]Mingde Zang, [11]Zhenggang Zhu, [12]Liping Su, [13]Yuan-Yuan Li, [14]Bingya Liu [Full author list] | EBioMedicine [missing] | DOI: 10.1016/J.EBIOM.2021.103436 [ORCID]
PubMed: 34157484 [ORCID]
| | 2021-06-19 | Beiqin Yu (Q89224934; 1 items)
|
| The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer | [1]Yanfei Jia, [2]Dongsheng Gu, [3]Jun Wan, [4]Beiqin Yu, [5]Xiaoli Zhang, [6]E Gabriela Chiorean, [7]Yunshan Wang, [8]Jingwu Xie [Full author list] | Oncogene [missing] | DOI: 10.1038/S41388-018-0553-0 [ORCID]
PubMed: 30382189 [ORCID]
| pancreatic cancer [missing] | 2018-10-31 | |
| Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer | [1]Ruolan Song, [2]Dongsheng Gu, [3]Lining Zhang, [4]Xiaoli Zhang, [5]Beiqin Yu, [6]Bingya Liu, [7]Jingwu Xie [Full author list] | Molecular Carcinogenesis [missing] | DOI: 10.1002/MC.22883 [ORCID]
PubMed: 30074279 [ORCID]
| colorectal cancer [missing] | 2018-08-22 | |
| The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer. | [1]Beiqin Yu, [2]Dongsheng Gu, [3]Xiaoli Zhang, [4]Bingya Liu, [5]Jingwu Xie [Full author list] | Journal of Genetics and Genomics [missing] | DOI: 10.1016/J.JGG.2017.04.008 [ORCID]
PubMed: 28847472 [ORCID]
| | 2017-07-25 | |
| The role of GLI1 for 5-Fu resistance in colorectal cancer | [1]Lining Zhang, [2]Ruolan Song, [3]Dongsheng Gu, [4]Xiaoli Zhang, [5]Beiqin Yu, [6]Bingya Liu, [7]Jingwu Xie [Full author list] | Cell & Bioscience [missing] | DOI: 10.1186/S13578-017-0145-7 [ORCID]
PubMed: 28413604 [ORCID]
| colorectal cancer [missing]; colorectal carcinoma [missing] | 2017-04-13 | |
| ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1/Rho GTPase signaling pathway | [1]Li Pang, [2]Jian-Fang Li, [3]Liping Su, [4]Mingde Zang, [5]Zhiyuan Fan, [6]Beiqin Yu, [7]Xiongyan Wu, [8]Chen Li, [9]Min Yan, [10]Zheng-Gang Zhu, [11]Bingya Liu [Full author list] | Journal of Gastroenterology [missing] | DOI: 10.1007/S00535-017-1329-Y [ORCID]
PubMed: 28315004 [ORCID]
| cancer metastasis [missing] | 2017-03-17 | Beiqin Yu (Q89224934; 1 items)
|
| GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer | [1]Beiqin Yu, [2]Dongsheng Gu, [3]Xiaoli Zhang, [4]Jianfang Li, [5]Bingya Liu, [6]Jingwu Xie [Full author list] | Oncotarget [missing] | DOI: 10.18632/ONCOTARGET.16174 [ORCID]
PubMed: 28404967 [ORCID]
| | 2017-03-14 | Beiqin Yu (Q89224934; 1 items)
|
| MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer | [1]Beiqin Yu, [2]Xin Lv, [3]Liping Su, [4]Jianfang Li, [5]Yingyan Yu, [6]Qinlong Gu, [7]Min Yan, [8]Zhenggang Zhu, [9]Bingya Liu [Full author list] | PLOS One [missing] | DOI: 10.1371/JOURNAL.PONE.0158961 [ORCID]
PubMed: 27518872 [ORCID]
| | 2016-08-12 | Beiqin Yu (Q89224934; 1 items)
|
| Characterization of differentially expressed genes involved in pathways associated with gastric cancer | [1]Hao Li, [2]Beiqin Yu, [3]Jianfang Li, [4]Liping Su, [5]Min Yan, [6]Jun Zhang, [7]Chen Li, [8]Zhenggang Zhu, [9]Bingya Liu [Full author list] | PLOS One [missing] | DOI: 10.1371/JOURNAL.PONE.0125013 [ORCID]
PubMed: 25928635 [ORCID]
| | 2015-04-30 | Beiqin Yu (Q89224934; 1 items)
|
| MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. | [1]Zhenqiang Wang, [2]Xingjie Ma, [3]Qiang Cai, [4]Xinjing Wang, [5]Beiqin Yu, [6]Qu Cai, [7]Bingya liu, [8]Zhenggang Zhu, [9]Chen Li [Full author list] | FEBS Letters [missing] | DOI: 10.1016/J.FEBSLET.2014.09.047 [ORCID]
PubMed: 25448600 [ORCID]
| | 2014-11-01 | Beiqin Yu (Q89224934; 1 items)
|
| Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV | [1]Yantao Duan, [2]Lei Hu, [3]Bing Liu, [4]Beiqin Yu, [5]Jianfang Li, [6]Min Yan, [7]Yingyan Yu, [8]Chen Li, [9]Liping Su, [10]Zhenggang Zhu, [11]Ming Xiang, [12]Bingya Liu, [13]Qiumeng Yang [Full author list] | Molecular Cancer [missing] | DOI: 10.1186/1476-4598-13-127 [ORCID]
PubMed: 24886316 [ORCID]
| | 2014-05-28 | Beiqin Yu (Q89224934; 1 items)
|
| MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. | [1]Junqing Wang, [2]Liping Su, [3]Xuehua Chen, [4]Pu Li, [5]Qu Cai, [6]Beiqin Yu, [7]Bingya Liu, [8]Weize Wu, [9]Zhenggang Zhu [Full author list] | Biomedicine and Pharmacotherapy [missing] | DOI: 10.1016/J.BIOPHA.2014.04.007 [ORCID]
PubMed: 24857172 [ORCID]
| | 2014-04-28 | Beiqin Yu (Q89224934; 1 items)
|
| CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126. | [1]Junqing Wang, [2]Xuehua Chen, [3]Pu Li, [4]Liping Su, [5]Beiqin Yu, [6]Qu Cai, [7]Jianfang Li, [8]Yingyan Yu, [9]Bingya Liu, [10]Zhenggang Zhu [Full author list] | Chemico-biological Interactions [missing] | DOI: 10.1016/J.CBI.2013.09.003 [ORCID]
PubMed: 24055140 [ORCID]
| | 2013-09-18 | Beiqin Yu (Q89224934; 1 items)
|
| Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer | [1]Yu Zhao, [2]Chenglong Li, [3]Ming Wang, [4]Liping Su, [5]Ying Qu, [6]Jianfang Li, [7]Beiqin Yu, [8]Min Yan, [9]Yingyan Yu, [10]Bingya Liu, [11]Zhenggang Zhu [Full author list] | PLOS One [missing] | DOI: 10.1371/JOURNAL.PONE.0069756 [ORCID]
PubMed: 23936094 [ORCID]
| | 2013-07-25 | Beiqin Yu (Q89224934; 1 items)
|
| Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP. | [1]Pu Li, [2]Xuehua Chen, [3]Liping Su, [4]Chenglong Li, [5]Qiaoming Zhi, [6]Beiqin Yu, [7]Hong Sheng, [8]Junqing Wang, [9]Runhua Feng, [10]Qu Cai, [11]Jianfang Li, [12]Yingyan Yu, [13]Min Yan, [14]Bingya Liu, [15]Zhenggang Zhu [Full author list] | PLOS One [missing] | DOI: 10.1371/JOURNAL.PONE.0066782 [ORCID]
PubMed: 23826132 [ORCID]
| | 2013-06-24 | Beiqin Yu (Q89224934; 1 items)
|
| Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression | [1]Beiqin Yu, [2]Xuehua Chen, [3]Jianfang Li, [4]Ying Qu, [5]Liping Su, [6]Yibing Peng, [7]Jian Huang, [8]Jun Yan, [9]Yingyan Yu, [10]Qinlong Gu, [11]Zhenggang Zhu, [12]Bingya Liu [Full author list] | BMC Cell Biology [missing] | DOI: 10.1186/1471-2121-14-17 [ORCID]
PubMed: 23510049 [ORCID]
| tumor metastasis [missing] | 2013-03-19 | Beiqin Yu (Q89224934; 1 items)
|
| Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer | [1]Xiongyan Wu, [2]Xuehua Chen, [3]Quan Zhou, [4]Pu Li, [5]Beiqin Yu, [6]Jianfang Li, [7]Ying Qu, [8]Jun Yan, [9]Yingyan Yu, [10]Min Yan, [11]Zhenggang Zhu, [12]Bingya Liu, [13]Liping Su [Full author list] | Cancer Letters [missing] | DOI: 10.1016/J.CANLET.2013.02.002 [ORCID]
PubMed: 23402812 [ORCID]
| | 2013-02-09 | Beiqin Yu (Q89224934; 1 items)
|
| Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer | [1]Xiaojian Tang, [2]Jianfang Li, [3]Beiqin Yu, [4]Liping Su, [5]Yingyan Yu, [6]Min Yan, [7]Bingya Liu, [8]Zhenggang Zhu [Full author list] | International Journal of Biological Sciences [missing] | DOI: 10.7150/IJBS.5280 [ORCID]
PubMed: 23289017 [ORCID]
| | 2012-12-20 | Beiqin Yu (Q89224934; 1 items)
|
| DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. | [1]Xiangyi He, [2]Zhong Zheng, [3]Jianfang Li, [4]Qiwen Ben, [5]Jun Liu, [6]Jianian Zhang, [7]Jun Ji, [8]Beiqin Yu, [9]Xuehua Chen, [10]Liping Su, [11]Lin Zhou, [12]Bingya Liu, [13]Yaozong Yuan [Full author list] | Carcinogenesis [missing] | DOI: 10.1093/CARCIN/BGS002 [ORCID]
PubMed: 22223849 [ORCID]
| pancreatic cancer [missing] | 2012-01-04 | Beiqin Yu (Q89224934; 1 items)
|
| Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer | [1]Lu Chen, [2]Liping Su, [3]Jianfang Li, [4]Yanan Zheng, [5]Beiqin Yu, [6]Yingyan Yu, [7]Min Yan, [8]Qinlong Gu, [9]Zhenggang Zhu, [10]Bingya Liu [Full author list] | Disease Markers [missing] | DOI: 10.1155/2012/473251 [ORCID]
PubMed: 22377736 [ORCID]
| hypermethylation [missing] | 2012-01-01 | Beiqin Yu (Q89224934; 1 items)
|
| Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis | [1]Yanan Zheng, [2]Lu Chen, [3]Jianfang Li, [4]Beiqin Yu, [5]Liping Su, [6]Xuehua Chen, [7]Yingyan Yu, [8]Min Yan, [9]Bingya Liu, [10]Zhenggang Zhu [Full author list] | Clinical Biochemistry [missing] | DOI: 10.1016/J.CLINBIOCHEM.2011.09.006 [ORCID]
PubMed: 21945024 [ORCID]
| biomarker [missing]; hypermethylation [missing]; cancer diagnosis [missing] | 2011-09-16 | Beiqin Yu (Q89224934; 1 items)
|
| Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil | [1]Zhong Zheng, [2]Jianfang Li, [3]Xiangyi He, [4]Xuehua Chen, [5]Beiqin Yu, [6]Jun Ji, [7]Jianian Zhang, [8]Tingfeng Wang, [9]Qinlong Gu, [10]Zhenggang Zhu, [11]Bingya Liu [Full author list] | Hepato-Gastroenterology [missing] | PubMed: 21410040 [ORCID]
| colon cancer [missing] | 2010-09-01 | Beiqin Yu (Q89224934; 1 items)
|
| miR-126 functions as a tumour suppressor in human gastric cancer | [1]Runhua Feng, [2]Xuehua Chen, [3]Yingyan Yu, [4]Liping Su, [5]Beiqin Yu, [6]Jianfang Li, [7]Qu Cai, [8]Min Yan, [9]Bingya Liu, [10]Zhenggang Zhu [Full author list] | Cancer Letters [missing] | DOI: 10.1016/J.CANLET.2010.06.004 [ORCID]
PubMed: 20619534 [ORCID]
| | 2010-07-08 | Beiqin Yu (Q89224934; 1 items)
|
| A novel plant homeodomain finger 10-mediated antiapoptotic mechanism involving repression of caspase-3 in gastric cancer cells | [1]Min Wei, [2]Bingya Liu, [3]Liping Su, [4]Jianfang Li, [5]Jun Zhang, [6]Yingyan Yu, [7]Min Yan, [8]Zhongyin Yang, [9]Xuehua Chen, [10]Jiayun Liu, [11]Xin Lv, [12]Hui Nie, [13]Qing Zhang, [14]Zhong Zheng, [15]Beiqin Yu, [16]Jun Ji, [17]Jianian Zhang, [18]Zhenggang Zhu, [19]Qinlong Gu [Full author list] | Molecular Cancer Therapeutics [missing] | DOI: 10.1158/1535-7163.MCT-09-1162 [ORCID]
PubMed: 20530714 [ORCID]
| | 2010-06-08 | Beiqin Yu (Q89224934; 1 items)
|